Figure 2. Changes in pulse wave velocity and peripheral resistance in patients on antihypertensive treatment at baseline and 2nd follow-up. *-between treatment groups at baseline; **-between treatment groups at 2nd follow-up; adjustedp – p value adjusted for baseline PWV or peripheral resistance values and age. A-lisinopril and/or lisinopril +hydrochlorothiazide; B-losartan and/or losartan + hydrochlorothiazide;. C-valsartan and/or valsartan +hydrochlorothiazide; D-lisinopril and/or lisinopril+hydrochlorothiazide and amlodipine; E-losartan and/or losartan + hydrochlorothiazide and amlodipine; F-valsartan and/or valsartan +hydrochlorothiazide and amlodipine.